ExEm Foam

Last updated on RxList: 11/13/2019
ExEm Foam Side Effects Center

Last reviewed on RxList 11/13/2019

What Is ExEm Foam?

ExEm Foam (air polymer-type A) is an ultrasound contrast agent indicated for sonohysterosalpingography to assess fallopian tube patency in women with known or suspected infertility.

What Are Side Effects of ExEm Foam?

Side effects of ExEm Foam include:

  • pelvic and abdominal pain,
  • nausea and faintness, and
  • post-procedure spotting

Dosage for ExEm Foam

The recommended dose of ExEm Foam is 2 mL to 3 mL by intrauterine infusion using a 5-Fr or larger catheter. The dose of ExEm Foam may be repeated in 2 mL to 3 mL increments, as needed, to achieve visualization of the fallopian tubes. The maximum total dose of ExEm Foam is 10 mL.

ExEm Foam In Children

The safety and effectiveness of ExEm Foam has not been established in pediatric patients.

What Drugs, Substances, or Supplements Interact with ExEm Foam?

ExEm Foam may interact with other medicines.

Tell your doctor all medications and supplements you use.

ExEm Foam During Pregnancy and Breastfeeding

ExEm Foam is not recommended for use during pregnancy; it may harm a fetus. Patients should have a negative pregnancy test within the 24 hours before ExEm Foam administration and should be in the pre-ovulatory phase of the menstrual cycle (cycle days 6 through 11). It is unknown if the components of ExEm Foam pass into breast milk. Consult your doctor before breastfeeding.

Additional Information

Our ExEm Foam (air polymer-type A) Intrauterine Foam Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Fertility Options: Types, Treatments, and Costs See Slideshow
ExEm Foam Professional Information


Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug may not reflect the rates observed in practice.

The common adverse reactions associated with ExEm Foam when used as indicated in sonohysterosalpingography are: pelvic and abdominal pain; vasovagal reactions and associated symptoms such as nausea and faintness; and post-procedure spotting.

Postmarketing Experience

The following adverse reactions have been identified during post-approval use of (air polymer-type A) intrauterine foam outside of the United States. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure:

Gynecologic Infections: pelvic inflammatory disease, salpingitis, and tubo-ovarian abscess

Read the entire FDA prescribing information for ExEm Foam (Air polymer-type A Intrauterine Foam)


Men and women are equally likely to have fertility problems. See Answer

© ExEm Foam Patient Information is supplied by Cerner Multum, Inc. and ExEm Foam Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors